Cargando…
High Molecular Weight Fibroblast Growth Factor-2 in the Human Heart Is a Potential Target for Prevention of Cardiac Remodeling
Fibroblast growth factor 2 (FGF-2) is a multifunctional protein synthesized as high (Hi-) and low (Lo-) molecular weight isoforms. Studies using rodent models showed that Hi- and Lo-FGF-2 exert distinct biological activities: after myocardial infarction, rat Lo-FGF-2, but not Hi-FGF-2, promoted sust...
Autores principales: | Santiago, Jon-Jon, McNaughton, Leslie J., Koleini, Navid, Ma, Xin, Bestvater, Brian, Nickel, Barbara E., Fandrich, Robert R., Wigle, Jeffrey T., Freed, Darren H., Arora, Rakesh C., Kardami, Elissavet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020823/ https://www.ncbi.nlm.nih.gov/pubmed/24827991 http://dx.doi.org/10.1371/journal.pone.0097281 |
Ejemplares similares
-
Non-mitogenic FGF2 protects cardiomyocytes from acute doxorubicin-induced toxicity independently of the protein kinase CK2/heme oxygenase-1 pathway
por: Koleini, Navid, et al.
Publicado: (2018) -
Fibroblast growth factor-2-mediated protection of cardiomyocytes from the toxic effects of doxorubicin requires the mTOR/Nrf-2/HO-1 pathway
por: Koleini, Navid, et al.
Publicado: (2017) -
Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity
por: Koleini, Navid, et al.
Publicado: (2017) -
SKI activates the Hippo pathway via LIMD1 to inhibit cardiac fibroblast activation
por: Landry, Natalie M., et al.
Publicado: (2021) -
A Cardiac Mitochondrial FGFR1 Mediates the Antithetical Effects of FGF2 Isoforms on Permeability Transition
por: Srisakuldee, Wattamon, et al.
Publicado: (2021)